Eldon C. Mayer III Insider Trading $RIGL RIGEL PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eldon C. Mayer III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eldon C. Mayer III. Eldon C. Mayer III is EVP & Chief Commercial Officer in RIGEL PHARMACEUTICALS INC ($RIGL) and EVP &Chief Commercial Officer in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and Ex VP & Chief Commerc. Officer in Eiger BioPharmaceuticals, Inc. ($EIGR).
Eldon C. Mayer III in RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eldon C. Mayer III: EVP & Chief Commercial Officer, EVP &Chief Commercial Officer
Holdings: 165,000 shares
Current Value: $404,250
Latest Transaction: Nov 20 2019
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Eldon C. Mayer III in RIGEL PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20 2019 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Option Exercise | A | 4.49 | 75,000 | 336,750 | 75,000 | |
| Mar 22 2019 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Option Exercise | A | 4.49 | 75,000 | 336,750 | 75,000 | |
| Jan 25 2019 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Option Exercise | A | 2.00 | 200,000 | 400,000 | 200,000 | |
| Sep 12 2018 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Buy | P | 3.23 | 50,000 | 161,340 | 215,000 | 165 K to 215 K (+30.30 %) |
| Sep 12 2018 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Buy | P | 3.28 | 50,000 | 164,210 | 165,000 | 115 K to 165 K (+43.48 %) |
| Aug 27 2018 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Buy | P | 2.82 | 100,000 | 282,320 | 115,000 | 15 K to 115 K (+666.67 %) |
| May 11 2018 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Option Exercise | A | 2.11 | 50,000 | 105,500 | 50,000 | |
| Jan 26 2018 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Option Exercise | A | 4.49 | 150,000 | 673,500 | 150,000 | |
| Feb 06 2017 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Option Exercise | A | 2.11 | 50,000 | 105,500 | 50,000 | |
| Oct 11 2016 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP &Chief Commerci ... | Option Exercise | A | 3.92 | 300,000 | 1,176,000 | 300,000 |
Page: 1